A Controlled Trial to Investigate the Efficacy and Safety of Frovatriptan to Prevent Menstrual Migraine - Related Studies

A Controlled Trial to Investigate the Efficacy and Safety of Frovatriptan to Prevent Menstrual Migraine

This study has been completed.

Study NCT00475514. Last updated on May 17, 2007. Information provided by Endo Pharmaceuticals

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Migraine

2	Additional conditions recognized in this trial
		Migraine Disorders

3	More general conditions related to this trial
		Brain Diseases
		Central Nervous System Diseases
		Headache Disorders
		Headache Disorders, Primary
		Nervous System Diseases

4	Interventions listed in this trial
		Frovatriptan 2.5mg QD
		Frovatriptan 2.5 mg BID
		placebo

5	Additional drug interventions recognized in this trial
		Frovatriptan

6	More general drug interventions related to this trial
		Molecular Mechanisms of Pharmacological Action
		Neurotransmitter Agents
		Pharmacologic Actions
		Physiological Effects of Drugs
		Serotonin Agents
		Serotonin Agonists

7	Sponsors listed in this trial
		Endo Pharmaceuticals